San Raffaele
Immunology in Italy typically costs from $3,700 to $11,300. The total expense depends on whether you seek private treatment, the complexity of the immune disorder, and the specific therapy required, such as stem cells or biologics. Patients can expect 30-50% savings compared to the US.
Typical Immunology Costs in Italy
Most specialized immunology centers are located in Milan, Rome, and Genoa. While prices are relatively consistent across major medical hubs, a consultation with a specialist can help you get accurate pricing and a tailored treatment plan for your specific condition.
| إيطاليا | تركيا | إسبانيا | |
| المعالجة بالدم السري | من $10,000 | من $5,000 | من $7,500 |
| العلاج الوريدي بالكركمين | من $450 | من $350 | من $450 |
| البلازما | من $2,200 | من $1,200 | من $1,800 |
| علاج تعزيز المناعة | من $3,800 | من $2,200 | - |
| تبادل البلازما | من $2,250 | من $3,900 | - |
Bookimed لا يضيف رسوماً إضافية على أسعار علاج أمراض المناعة والحساسية. الأسعار مأخوذة من قوائم الأسعار الرسمية للعيادات. تدفع مباشرة في العيادة مقابل علاجك عند وصولك إلى البلد.
Bookimed ملتزم بسلامتك. نحن نعمل فقط مع المؤسسات الطبية التي تحافظ على معايير دولية عالية في علاج أمراض المناعة والحساسية ولديها التراخيص اللازمة لخدمة المرضى الدوليين في جميع أنحاء العالم.
Bookimed يقدم مساعدة خبراء مجانية. منسق طبي شخصي يدعمك قبل وأثناء وبعد العلاج، ويحل أي مشاكل. لن تكون وحيداً أبداً في رحلة علاج أمراض المناعة والحساسية.
يقود البروفيسور أيوتي أبحاثاً رائدة في العلاج الجيني لنقص المناعة النادر في مستشفى سان رافاييل، مع أكثر من 180 منشوراً في هذا المجال.
تم اختياره كـ "خبير عالمي في الأمراض المرتبطة بـ IgG4" من قبل Expertscape، ويقود الدكتور ديلا توري عيادات متخصصة في مستشفى سان رافاييل.
Advanced cancer immunotherapies like CAR T-cell therapy are available in Italy. The Italian Medicines Agency (AIFA) authorizes these treatments for specific blood cancers. Leading centers in Milan and Rome provide clinical access. Specialized facilities like San Raffaele also offer advanced gene therapies.
Bookimed Expert Insight: Milan has become the primary hub for Italian immunotherapy. Clinics like San Raffaele combine research with clinical care, serving 300,000 patients annually. Our data shows these IRCCS-accredited centers often manage the highest volume of complex immune cases. Patients should target these large research hospitals to find the widest range of active clinical trials.
Patient Consensus: Patients note that while treatment is highly effective for blood cancers, the approval process can take three months. It is important to prepare for travel to major northern hubs like Milan because specialized care is rarely available at smaller local hospitals.
San Raffaele Hospital and Humanitas Research Hospital in Milan are globally recognized for treating rare immune disorders. San Raffaele pioneered the world first stem cell gene therapy for ADA-SCID. These centers hold IRCCS accreditation. This status marks them as premier Italian research institutes for molecular medicine.
Bookimed Expert Insight: Data shows that Milan is the primary hub for rare immunology. Clinics like San Raffaele and San Donato serve 300,000 patients yearly. Their IRCCS status is a key quality signal. This accreditation means they receive direct government funding for advanced clinical trials. Patients should prioritize these research-heavy centers for complex or undiagnosed immune conditions.
Patient Consensus: Patients note that San Raffaele is a top choice for primary immunodeficiencies and advanced trials. Many emphasize its collaboration with international institutions as a major factor for choosing Milan for rare disease care.
Italy offers new EMA-approved biologics like Anifrolumab for lupus and Bimekizumab for psoriatic arthritis. Targeted oral JAK inhibitors including Upadacitinib and Filgotinib are also widely available. These therapies are accessible through specialized IRCCS centers like San Raffaele and Humanitas Research Hospital in Milan.
Bookimed Expert Insight: Data from Milanese centers shows a high concentration of expertise in rare autoimmune conditions. Dr. Emanuele Della Torre at San Raffaele is a recognized global expert in IgG4-related diseases. Patients often find faster access to clinical trials and the latest AIFA-approved molecules at these research-heavy IRCCS institutions compared to general hospitals.
Patient Consensus: Patients note that starting documentation of previous treatment failures immediately helps speed up the approval process. Those treated in Northern Italy often report significantly shorter wait times for the newest drug listings than in Southern regions.
Allergen immunotherapy (AIT) accessibility in Italy remains highly variable due to regional reimbursement policies. The National Health System (SSN) covers grass pollen treatments for specific groups. However, patients often face full costs for other allergens like house dust mites depending on their local residence.
Bookimed Expert Insight: Patients seeking AIT should prioritize clinics with IRCCS accreditation, such as San Raffaele or San Donato. This Italian Ministry of Health certification signals a research-driven environment. These institutions often handle 300,000+ patients annually. Their high volume and academic links, featuring experts like Dr. Emanuele Della Torre, ensure access to the latest immunological protocols.
Patient Consensus: Patients note that sublingual therapy is the most convenient option for home use. Many emphasize the need to self-advocate or seek second opinions to successfully navigate the public reimbursement process.
Italy is a leader in immunology, offering safe treatment through JCI-accredited facilities and specialised research hospitals. Centres like San Raffaele in Milan pioneered therapies for immunodeficiencies like ADA-SCID. These hospitals maintain strict European Union safety standards for gene and molecular therapies.
Bookimed Expert Insight: Italian research hospitals often treat 300,000+ patients annually. This volume drives massive data for rare immune disorders. Clinics with IRCCS status, like San Donato Hospital, are monitored by the Ministry of Health. This link helps patients access treatments still in trial phases elsewhere.
Patient Consensus: Patients note it is essential to check if Italian clinics can handle international records. They highlight the importance of obtaining full pathology results. These should be in formats that Australian specialists can easily read upon return.
CAR-T cell therapies and monoclonal antibodies are available and integrated into Italy's healthcare system. Leading research centres like San Raffaele in Milan provide these treatments for haematological cancers and rare immune disorders. Facilities often hold IRCCS accreditation, marking them as national centres of excellence.
Bookimed Expert Insight: San Raffaele stands out because it performed the world's first stem cell therapy for ADA-SCID. While many clinics offer standard care, this hospital provides custom methods for rare genetic and immune diseases. Patients should look for hospitals with IRCCS status. These centres receive specific government funding for experimental immunology research.
Patient Consensus: Patients note it is vital to confirm if therapies are routine or part of clinical trials. They suggest verifying that specialists work in high-volume Italian centres before making travel arrangements from Australia.
Italian specialists treat systemic autoimmune diseases, primary immunodeficiencies, and rare fibro-inflammatory disorders. Leading Milanese research hospitals use gene therapy and biologics for complex cases. These centres focus on conditions like lupus, rheumatoid arthritis, and Severe Combined Immune Deficiency (SCID).
Bookimed Expert Insight: Italian research hospitals like San Raffaele and Humanitas hold IRCCS accreditation. This Italian designation means they combine clinical care with active laboratory research. For patients with rare immune disorders, this provides access to experimental therapies. It also offers protocols not yet available in standard hospitals.
Patient Consensus: Patients in Italy value the multidisciplinary approach. Here, immunologists work with other specialists to understand complex mechanisms. They suggest bringing a full infection history and previous blood tests. This help doctors identify the specific immune trigger.
Australian patients usually stay in Italy for 2 to 3 weeks for immunology treatment. This period covers initial diagnostics, starting treatment, and clinical observation. Complex cases involving stem cell or gene therapy may require stays longer than 1 month.
Bookimed Expert Insight: Milan is the primary hub for immunology. Facilities like San Raffaele handle 300,000+ patients annually. Our data shows that researchers like Dr Alessandro Aiuti often combine research with clinical care. This can streamline access to gene therapies. Choosing a facility with IRCCS accreditation ensures patients are treated at a government-recognised research centre.
Patient Consensus: Patients note it is important to confirm how many in-person visits are required. Many found that planning extra time for potential delayed reactions helped avoid stressful travel changes.
English is generally workable in major Italian hospitals. This is true in international hubs like Milan. Doctors and specialists often speak passable to excellent English. However, nursing and administrative staff may have limited proficiency. Major JCI-accredited centres and university hospitals usually offer the best communication standards.
Bookimed Expert Insight: Milan serves as Italy's primary medical hub for international care. Its top hospitals, such as San Raffaele and San Donato, are university-linked. Doctors there, including experts like Dr Emanuele Della Torre, frequently publish research in English. Many have trained at institutions like Harvard. This academic environment makes clinical consultations easier for English speakers than at regional public clinics.
Patient Consensus: Patients find that speaking with doctors in Italy is manageable. They suggest bringing a printed one-page medical summary translated into Italian. It is helpful to use translation apps for routine ward interactions and admission paperwork.
Italian immunology clinics do not offer pre-built all-inclusive packages. Instead, specialists at major centres like Humanitas Research Hospital provide bespoke treatment programs. These custom plans cover diagnostics, immunotherapy, and logistics for complex cases. These include primary immunodeficiencies and rare autoimmune diseases.
Bookimed Expert Insight: Milan serves as Italy's immunology hub. Centres like San Raffaele handle both research and clinical treatment. This allows patients to access new therapies, like stem cell treatments for ADA-SCID, alongside standard care. Choosing a research-focused clinic often provides access to clinical trials and diagnostic immune mapping.
Patient Consensus: Patients note it is essential to get itemised quotes in writing. This clarifies if lab work and follow-up plans are included. They emphasise asking for results in a format Australian GPs can easily use for ongoing monitoring after returning home.
San Raffaele and Humanitas Research Hospital are the top-rated immunology hospitals in Italy for international patients. These Milan-based centres specialise in rare immune disorders. They also pioneered the world’s first gene therapy for ADA-SCID. Most facilities hold JCI accreditation or IRCCS status for high medical standards.
Bookimed Expert Insight: Italian research hospitals like San Raffaele handle clinical care and laboratory research in one facility. Our data shows this integration gives patients access to experimental treatments. These include gene therapies and antiretroviral regimens not yet available in many other countries. This setup often shortens the path from diagnosis to specialised treatment for rare immune conditions.
Patient Consensus: Patients value how Italian specialists manage every step from diagnosis through to surgery. They specifically note the helpfulness of dedicated units in Milan. These units help patients navigate complex medical records and local logistics.